Literature DB >> 22760742

Sex differences in human lymphoblastoid cells sensitivities to antipsychotic drugs.

Ayelet Morag1, Keren Oved, David Gurwitz.   

Abstract

Adverse drug reactions (ADRs) are a major concern in pharmacotherapy and are more common among women. Immortalized human lymphoblastoid cell lines (LCLs) are emerging as a novel tool for studying interindividual variability in drug response, including ADRs. In the present study, we compared sensitivities of LCLs from unrelated healthy male and female donors to growth inhibition by a panel of common drugs. We observed large interindividual drug sensitivity variations with similar mean sensitivities recorded for LCLs from male and female donors for most tested drugs. A notable exception was observed for the typical antipsychotic haloperidol and the atypical antipsychotic risperidone, which exhibited, on average, more robust in vitro growth inhibition in male as compared with female LCLs. An opposite finding was observed for the antidepressant paroxetine, which was more potent for inhibiting the growth of female as compared with male LCLs. These observations are discussed in the context of the higher incidence of dystonia reported for male schizophrenia patients treated with haloperidol and the higher efficacy of paroxetine in female major depression patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22760742     DOI: 10.1007/s12031-012-9852-z

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  22 in total

1.  National surveillance of emergency department visits for outpatient adverse drug events.

Authors:  Daniel S Budnitz; Daniel A Pollock; Kelly N Weidenbach; Aaron B Mendelsohn; Thomas J Schroeder; Joseph L Annest
Journal:  JAMA       Date:  2006-10-18       Impact factor: 56.272

2.  Drug-induced dystonia in young and elderly patients.

Authors:  G Addonizio; G S Alexopoulos
Journal:  Am J Psychiatry       Date:  1988-07       Impact factor: 18.112

3.  Heritable and non-genetic factors as variables of pharmacologic phenotypes in lymphoblastoid cell lines.

Authors:  A L Stark; W Zhang; S Mi; S Duan; P H O'Donnell; R S Huang; M E Dolan
Journal:  Pharmacogenomics J       Date:  2010-02-09       Impact factor: 3.550

Review 4.  Specificity profile of paroxetine in major depressive disorder: meta-regression of double-blind, randomized clinical trials.

Authors:  Alessandro Serretti; Sara Gibiino; Antonio Drago
Journal:  J Affect Disord       Date:  2010-09-21       Impact factor: 4.839

5.  Sex-related differences in hospital admissions attributed to adverse drug reactions in the Netherlands.

Authors:  Eline M Rodenburg; Bruno H Ch Stricker; Loes E Visser
Journal:  Br J Clin Pharmacol       Date:  2011-01       Impact factor: 4.335

6.  Genome-wide expression profiling of human lymphoblastoid cell lines identifies CHL1 as a putative SSRI antidepressant response biomarker.

Authors:  Ayelet Morag; Metsada Pasmanik-Chor; Varda Oron-Karni; Moshe Rehavi; Julia C Stingl; David Gurwitz
Journal:  Pharmacogenomics       Date:  2011-02       Impact factor: 2.533

Review 7.  Role of haloperidol in palliative medicine: an update.

Authors:  Eric Prommer
Journal:  Am J Hosp Palliat Care       Date:  2011-10-13       Impact factor: 2.500

8.  Sex-related variations in the frequency and characteristics of adverse drug reactions.

Authors:  C Domecq; C A Naranjo; I Ruiz; U Busto
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1980

9.  Gene set enrichment analyses revealed differences in gene expression patterns between males and females.

Authors:  Wei Zhang; R Stephanie Huang; Shiwei Duan; M Eileen Dolan
Journal:  In Silico Biol       Date:  2009

10.  Pharmacogenomic study of side-effects for antidepressant treatment options in STAR*D.

Authors:  S L Clark; D E Adkins; K Aberg; J M Hettema; J L McClay; R P Souza; E J C G van den Oord
Journal:  Psychol Med       Date:  2011-11-01       Impact factor: 7.723

View more
  5 in total

1.  Relationships between low-grade peripheral inflammation and psychotropic drugs in schizophrenia: results from the national FACE-SZ cohort.

Authors:  G Fond; N Resseguier; F Schürhoff; O Godin; M Andrianarisoa; L Brunel; E Bulzacka; B Aouizerate; F Berna; D Capdevielle; I Chereau; T D'Amato; C Dubertret; J Dubreucq; C Faget; F Gabayet; C Lançon; P M Llorca; J Mallet; D Misdrahi; C Passerieux; R Rey; A Schandrin; M Urbach; P Vidailhet; L Boyer; M Leboyer
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-11-10       Impact factor: 5.270

2.  Comparable impediment of cognitive function in female and male rats subsequent to daily administration of haloperidol after traumatic brain injury.

Authors:  Kristin E Free; Anna M Greene; Corina O Bondi; Naima Lajud; Patricia B de la Tremblaye; Anthony E Kline
Journal:  Exp Neurol       Date:  2017-07-08       Impact factor: 5.330

3.  Dihydrotestosterone suppression of proinflammatory gene expression in human meibomian gland epithelial cells.

Authors:  Afsun Sahin; Yang Liu; Wendy R Kam; Raheleh Rahimi Darabad; David A Sullivan
Journal:  Ocul Surf       Date:  2020-02-27       Impact factor: 5.033

4.  Gene expression profiling of the response to interferon beta in Epstein-Barr-transformed and primary B cells of patients with multiple sclerosis.

Authors:  Rana Khsheibun; Tamar Paperna; Anat Volkowich; Izabella Lejbkowicz; Nili Avidan; Ariel Miller
Journal:  PLoS One       Date:  2014-07-15       Impact factor: 3.240

5.  Protein quantitative trait loci identify novel candidates modulating cellular response to chemotherapy.

Authors:  Amy L Stark; Ronald J Hause; Lidija K Gorsic; Nirav N Antao; Shan S Wong; Sophie H Chung; Daniel F Gill; Hae K Im; Jamie L Myers; Kevin P White; Richard Baker Jones; M Eileen Dolan
Journal:  PLoS Genet       Date:  2014-04-03       Impact factor: 5.917

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.